Home National Biden Proposes Medicare and Medicaid Coverage for Costly Weight-Loss Drugs

Biden Proposes Medicare and Medicaid Coverage for Costly Weight-Loss Drugs

by Sonia Park
Biden Proposes Medicare and Medicaid Coverage for Costly Weight-Loss Drugs

The Biden administration unveils a groundbreaking proposal to extend Medicare and Medicaid coverage to popular weight-loss drugs such as Wegovy and Ozempic, marking a significant shift in federal healthcare policy. This rule aims to provide millions of Americans living with obesity access to treatments previously deemed too expensive for many to afford out-of-pocket.

https://youtu.be/3cuCWU_dCo0

The proposal, introduced Tuesday morning, seeks to address the growing obesity epidemic that affects over 40% of adults in the United States. Wegovy and Ozempic, manufactured by Novo Nordisk, are glucagon-like peptide-1. . .

You have exceeded the number of free content views. To continue viewing exclusive JudgeNap content,  you'll need a subscription. Please choose your subscription plan here.

Already a member?  Login here.

You may also like

0 0 votes
Article Rating
Subscribe
Notify of
0 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x
-
00:00
00:00
Update Required Flash plugin
-
00:00
00:00